AI assistant
ASP Isotopes Inc. — Director's Dealing 2022
Nov 14, 2022
32264_dirs_2022-11-14_e46d13dc-a32e-496b-8246-d5e143788405.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ASP Isotopes Inc. (ASPI)
CIK: 0001921865
Period of Report: 2022-11-09
Reporting Person: Ainscow Robert (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 250000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $0.25 | 2031-10-04 | Common Stock (150000) | Direct | |
| Employee Stock Option (right to buy) | $2.00 | 2032-04-04 | Common Stock (12000) | Direct | |
| Employee Stock Option (right to buy) | $2.00 | 2032-06-10 | Common Stock (135000) | Direct |
Footnotes
F1: Subject to the Reporting Person's continued service to the Issuer, the option becomes exercisable in thirty six equal monthly installments. The option was granted on October, 4, 2021
F2: Subject to the Reporting Person's continued service to the Issuer, the option becomes exercisable in a single installment 12 months after the grant date. The option was granted on April 4, 2022.
F3: Subject to the Reporting Person's continued service to the Issuer, the option becomes exercisable in thirty six equal installments beginning on the last day of month after the option's grant date. The option was granted on June, 10, 2022.